Brief: Cullinan Oncology Reports Q1 Loss Of 27 Cents Per Share

Cullinan Therapeutics

16/05/2022 11:49

May 16 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2022
FINANCIAL RESULTS
    * CULLINAN ONCOLOGY INC- ANNOUNCED U.S. CO-DEVELOPMENT AND
CO-COMMERCIALIZATION
AGREEMENT FOR CLN-081 WITH TAIHO PHARMACEUTICA
    * CULLINAN ONCOLOGY INC- CASH OF $685 MILLION, INCLUDING UPFRONT PAYMENT FOR
TAIHO
COLLABORATION, PROVIDES EXPECTED RUNWAY THROUGH 2026
    * CULLINAN ONCOLOGY INC - QTRLY LOSS PER SHARE $0.27

Source text for Eikon:  ID:nGNX15jXt7 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))